A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis.

A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis.

OBJECTIVE: To determine the current disease-modifying anti-rheumatic drug (DMARD) preferences of UK consultant rheumatologists. METHODS: A questionnaire was sent in May 2002. We asked which DMARD(s) was most frequently preferred first and sought the most typical sequence of DMARDs, including DMARD c...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Jobanputra, P, Wilson, J, Douglas, K, Burls, A
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2004

Míreanna comhchosúla

A SURVEY OF DMARD PREFERENCES OF UK RHEUMATOLOGISTS
de réir: Douglas, K, et al.
Foilsithe / Cruthaithe: (2003)

Doctors’ preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment
de réir: T. Martijn Kuijper, et al.
Foilsithe / Cruthaithe: (2017-04-01)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
de réir: Mysler E, et al.
Foilsithe / Cruthaithe: (2021-06-01)

When the first visit to the rheumatologist is established rheumatoid arthritis
de réir: Taylor, P, et al.
Foilsithe / Cruthaithe: (2020)

Myocardial infarction in rheumatoid arthritis: The effects of DMARDs and prednisolone
de réir: Edwards, C, et al.
Foilsithe / Cruthaithe: (2008)

Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
de réir: Michael D George, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Periodontal Health as Perceived by Rheumatologists and Rheumatoid Arthritis Patients
de réir: Natasha Proud, et al.
Foilsithe / Cruthaithe: (2023-04-01)

DIAGNOSTIC MARKERS AND CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING DMARDS
de réir: Maria Sergeevna Voronina, et al.
Foilsithe / Cruthaithe: (2012-10-01)

Biomarkers to Predict DMARDs Efficacy and Adverse Effect in Rheumatoid Arthritis
de réir: Kai Wei, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Clinical evaluation of DMARDs and NSAIDs in cases of Rheumatoid arthritis in Chhattisgarh
de réir: Basant Kumar Maheshwari
Foilsithe / Cruthaithe: (2018-01-01)

Healthcare professionals’ perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis
de réir: M. J. H. Voshaar, et al.
Foilsithe / Cruthaithe: (2022-01-01)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
de réir: Jobanputra, P, et al.
Foilsithe / Cruthaithe: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
de réir: Jobanputra, P, et al.
Foilsithe / Cruthaithe: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
de réir: P. Jobanputra, et al.
Foilsithe / Cruthaithe: (2002-01-01)

Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
de réir: Juthamas Prawjaeng, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia
de réir: Rafael Mendonça da Silva Chakr, et al.

A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference
de réir: Hamre HJ, et al.
Foilsithe / Cruthaithe: (2018-03-01)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.
de réir: Barton, P, et al.
Foilsithe / Cruthaithe: (2004)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.
de réir: Barton, P, et al.
Foilsithe / Cruthaithe: (2004)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis
de réir: P Barton, et al.
Foilsithe / Cruthaithe: (2004-03-01)

Elderly-onset rheumatoid arthritis: an outlook from a practicing rheumatologist
de réir: Ch. Baimukhamedov
Foilsithe / Cruthaithe: (2020-09-01)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis - Introduction
de réir: Barton, P, et al.
Foilsithe / Cruthaithe: (2004)

Patients’ and rheumatologists’ perceptions on preventive intervention in rheumatoid arthritis and axial spondyloarthritis
de réir: Laurette van Boheemen, et al.
Foilsithe / Cruthaithe: (2020-09-01)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
de réir: Clark, W, et al.
Foilsithe / Cruthaithe: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
de réir: Clark, W, et al.
Foilsithe / Cruthaithe: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
de réir: Clark, W, et al.
Foilsithe / Cruthaithe: (2004)

Individual DMARDs have different effects on the likelihood of developing septic arthritis in adults with rheumatoid arthritis
de réir: Edwards, C, et al.
Foilsithe / Cruthaithe: (2005)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
de réir: W Clark, et al.
Foilsithe / Cruthaithe: (2004-09-01)

COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs
de réir: James Cheng-Chung Wei, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Identification of biomarkers in patients with rheumatoid arthritis responsive to DMARDs but with progressive bone erosion
de réir: Emiliano Marasco, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Common Transcriptomic Effects of Abatacept and Other DMARDs on Rheumatoid Arthritis Synovial Tissue
de réir: Clement Triaille, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Safety and efficacy of newer biologics DMARDs in the management of rheumatoid arthritis: A systematic review
de réir: Basiru Ahmad Zago, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope
de réir: Tillett, W, et al.
Foilsithe / Cruthaithe: (2020)

Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients
de réir: Hazan Karadeniz, et al.
Foilsithe / Cruthaithe: (2022-04-01)

The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs
de réir: Soo-Kyung Cho, et al.
Foilsithe / Cruthaithe: (2017-12-01)

Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis
de réir: Esteban A. Gomez, et al.
Foilsithe / Cruthaithe: (2020-10-01)

Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study
de réir: Seogsong Jeong, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Challenges in implementing treat-to-target in rheumatoid arthritis: a perspective from Brazilian rheumatologists
de réir: Adriana Maria Kakehasi, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making
de réir: Bolge SC, et al.
Foilsithe / Cruthaithe: (2016-06-01)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
de réir: Ruiz Garcia, V, et al.
Foilsithe / Cruthaithe: (2014)